ACUT

ACCUSTEM SCIENCES INC by Accustem Sciences Inc. (ACUT)

About ACCUSTEM SCIENCES INC by Accustem Sciences Inc. (ACUT)

AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer. The company was founded by Gabriele Marco Antonio Cerrone on June 5, 2020 and is headquartered in New York, NY.

Details

Daily high

$0.63

Daily low

$0.57

Price at open

$0.57

52 Week High

$2.33

52 Week Low

$0.23

Market cap

10.2M

Dividend yield

0.00%

Volume

658

Avg. volume

1,340

P/E ratio

-5.46

ACCUSTEM SCIENCES INC by Accustem Sciences Inc. News

Details

Daily high

$0.63

Daily low

$0.57

Price at open

$0.57

52 Week High

$2.33

52 Week Low

$0.23

Market cap

10.2M

Dividend yield

0.00%

Volume

658

Avg. volume

1,340

P/E ratio

-5.46